Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 3, 2011, Pages

  Ledeganck, Kristien J ^a   Boulet, Gaëlle A ^b   Horvath, Caroline A ^b   Vinckx, Marleen ^a   Bogers, Johannes J ^b   van den Bossche, Rita ^b   Verpooten, Gert A ^a,c   de Winter, Benedicte Y ^a  

^a Laboratory of Experimental Medicine and Pediatrics   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Claudin 16; Claudin 19; Magnesium; Renin angiotensin aldosterone system; Sodium

Indexed keywords

ALDOSTERONE; CLAUDIN; CLAUDIN 16; CLAUDIN 19; CREATININE; CYCLOSPORIN A; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MAGNESIUM ION; MESSENGER RNA; POTASSIUM ION; PREPRORENIN; RECOMBINANT EPIDERMAL GROWTH FACTOR; SODIUM CHLORIDE COTRANSPORTER; SODIUM ION; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN REGULATION; EXPERIMENTAL MODEL; HOMEOSTASIS; HYPOMAGNESEMIA; HYPONATREMIA; KIDNEY DISTAL TUBULE; MAGNESIUM URINE LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; URINARY EXCRETION;

EID: 80052411965     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00116.2011     Document Type: Article

References (53)

1. Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, Nakao T, Okamura M, Kim S, Iwao H, Miura K. Magnesium supplementation prevents experimental chronic CsA a nephrotoxicity via reninangiotensin system independent mechanism. Transplantation 74: 784-791, 2002.
2. Bantle JP, Nath KA, Sutherland DE, Najarian JS, Ferris TF. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 145: 505-508. 1985.
3. Barton CH, Vaziri ND, Martin DC, Choi S, Alikhani S. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving CsA. Am J Med 83: 693-699, 1987.
4. Breider MA, Bleavins MR, Reindel JF, Gough AW, de la Iglesia FA. Cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor. Vet Pathol 33: 184-194, 1996.
5. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 23: 465-476, 2003.
6. Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev 231: 59-87, 2009.
7. Chang CT, Hung CC, Tian YC, Yang CW, Wu MS. Ciclosporin reduces paracellin-1 expression and magnesium transport in thick ascending limb cells. Nephrol Dial Transplant 22: 1033-1040, 2007.
8. Chubanov V, Schlingmann KP, Wäring J, Heinzinger J, Kaske S, Waldegger S, Mederos Y, Schnitzler M, Gudermann T. Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative pore-forming region of TRPM6. J Biol Chem 282: 7656-7667, 2007.
9. Deng JT, Verpooten GA, Malesys J, Verstrepen WA, Nouwen EJ, De Broe ME. Decreased renal epidermal growth factor expression in CsA treated rats. Transpl Proc 26: 2842-2844, 1994.
10. Duymelinck C, Dauwe SE, Nouwen EJ, De Broe ME, Verpooten GA. Cholesterol feeding accentuates the CsA-induced elevation of renal plasminogen activator inhibitor type 1. Kidney Int 51: 1818-1830, 1997.
11. Duymelinck C, Deng JT, Dauwe SE, De Broe ME, Verpooten GA. Inhibition of the matrix metalloproteinase system in a rat model of chronic CsA nephropathy. Kidney Int 54: 804-818, 1998.
12. Erman A, Chen-Gal B, Rosenfeld J. The role of eicosanoids in cyclosporine nephrotoxicity in the rat. Biochem Pharmacol 38: 2153-2157, 1989.
13. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitorsparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22: 1-15, 2008.
14. Fujigaki Y, Sakakima M, Sun Y, Goto T, Ohashi N, Fukasawa H, Tsuji T, Yamamoto T, Hishida A. Immunohistochemical study on caveolin-1alpha in regenerating process of tubular cells in gentamicininduced acute tubular injury in rats. Virchows Arch 450: 671-681, 2007.
15. - cotransporter: molecular biology, functional properties, and regulation by WNKs. Am J Physiol Renal Physiol 297: F838-F848, 2009.
16. Groenestege WM, Thébault S, van der Wijst J, van den Berg D, Janssen R, Tejpar S, van den Heuvel LP, van Cutsem E, Hoenderop JG, Knoers NV, Bindels RJ. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 117: 2260-2267, 2007.
17. Henck JW, Reindel JF, Anderson JA. Growth and development in rats given recombinant human epidermal growth factor (1- 48) as neonates. Toxicol Sci 62: 80-91, 2001.
18. Higgins R, Ramaiyan K, Dasgupta T, Kanji H, Fletcher S, Lam F, Kashi H. Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporine. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transplant; 19: 444-450, 2004.
19. 2+ channels in health and disease. J Am Soc Nephrol 16: 15-26, 2005.
20. Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens 19: 483-488, 2010.
21. Ikari A, Okude C, Sawada H, Takahashi T, Sugatani J, Miwa M. Down-regulation of TRPM6-mediated magnesium influx by CsA. Naunyn- Schmiedeberg's Arch Pharmacol 377: 333-343, 2007.
22. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol 286: F599-F605, 2004.
23. Leonard I, Zanen J, Nonclercq D, Toubeau G, Heuson-Stiennon JA, Beckers JF, Falmagne P, Schaudies RP, Laurent G. Modification of immunoreactive EGF and EGF receptor after acute tubular necrosis induced by tobramycin or cisplatin. Ren Fail 16: 583-608, 1994.
24. Li C, Yang CW, Kim WY, Jung JY, Cha JH, Kim YS, Kim J, Bennett WM, Bang BK. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 284: F389-F398, 2003.
25. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 127: 525-537, 2006.
26. Lim SW, Li C, Sun BK, Han KH, Kim WY, Oh YW, Lee JU, Kador PF, Knepper MA, Sands JM, Kim J, Yang CW. Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney. Am J Physiol Renal Physiol 287: F139-F151, 2004.
27. Loffing J, Kaissling B. Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol 284: F628-F643, 2003.
28. Miura K, Nakatani T, Asai T, Yamanaka S, Tamada S, Tashiro K, Kim S, Okamura M, Iwao H. Role of hypomagnesemia in chronic CsA nephropathy. Transplantation 73: 340-347, 2002.
29. Mueller XM. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg 77: 354-362, 2004.
30. Myers BD, Sibley R, Newton L, Tomlanovich SJ, Boshkos C, Stinson E, Luetscher JA, Whitney DJ, Krasny D, Coplon NS. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 33: 590-600, 1988.
31. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. LTRPC7 is a Mg ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001.
32. 2+ transport proteins in kidney. Kidney Int 64: 555-564, 2003.
33. 2+ transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 15: 549-557, 2004.
34. Ohtomo S, Izuhara Y, Takizawa S, Yamada N, Kakuta T, van Ypersele de Strihou C, Miyata T. Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model. Kidney Int 72: 1512-1519, 2007.
35. Rosen S, Greenfeld Z, Brezis M. Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. Transplantation 49: 445-452, 1990.
36. Ryu HH, Kim HL, Chung JH, Lee BR, Kim TH, Shin BC. Renoprotective effects of green tea extract on renin-angiotensin-aldosterone system in chronic cyclosporine-treated rats. Nephrol Dial Transplant 26: 1188-1193, 2011.
37. - cotransporter to apical membrane. Am J Physiol Renal Physiol 293: F662-F669, 2007.
38. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31: 166-170, 2002.
39. Stefanidou V, Liakopoulos V, Eleftheriadis T, Anifandis G, Mertens PR, Kanelaki E, Stefanidis I. Expression of transforming growth factorbeta receptor II mRNA in cyclosporine-induced gingival overgrowth. Transplant Proc 38: 2905-2908, 2006.
40. Steinmetz OM, Panzer U, Fehr S, Meyer-Schwesinger C, Stahl RA, Wenzel UO. A pitfall of glomerular sieving: profibrotic and matrix proteins derive from the Bowman's capsule and not the glomerular tuft in rats with renovascular hypertension. Nephrol Dial Transplant 22: 3055-3060, 2007.
41. Thébault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 20: 78-85, 2009.
42. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 294: H1103-H1118, 2008.
43. Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ. Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int 43: 615-622, 1993.
44. van der Lubbe N, Lim CH, Fenton RA, Meima ME, Jan Danser AH, Zietse R, Hoorn EJ. Angiotensin II induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter independent of aldosterone. Kidney Int 79: 66-76, 2011.
45. van Neck JW, Berghout EM, Vinter-Jensen L, Groffen CA, Cingel V, Dits NF, Drop SL, Flyvbjerg A. The effect of epidermal growth factor and IGF-I infusion on hepatic and renal expression of the IGF-system in adult female rats. J Endocrinol 165: 115-122, 2000.
46. van Roeyen CR, Eitner F, Scholl T, Boor P, Kunter U, Planque N, Gröne HJ, Bleau AM, Perbal B, Ostendorf T, Floege J. CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int 73: 86-94, 2008.
47. Verpooten GA, Wybo I, Pattyn VM, Hendrix PG, Giuliano RA, Nouwen EJ, Roels F, De Broe ME. Cyclosporine nephrotoxicity: comparative cytochemical study of rat kidney and human allograft biopsies. Clin Nephrol 1: 18-22, 1986.
48. Verpooten GA, Cools FJ, Van der Planken MG, Bedert LC, Claes R, Van Gaal LF, De Broe ME. Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients. Nephrol Dial Transplant 11: 347-351, 1996.
49. 2+ absorption. J Biol Chem 2: 19-25, 2004.
50. Waiser J, Dell K, Böhler T, Dogu E, Gaedeke J, Budde K, Neumayer HH. CsA up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant 17: 1568-1577, 2002.
51. Wheatley HC, Datzman M, Williams JW, Miles DE, Hatch FE. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 43: 641-647, 1987.
52. Wongdee K, Pandaranandaka J, Teerapornpuntakit J, Tudpor K, Thongbunchoo J, Thongon N, Jantarajit W, Krishnamra N, Charoenphandhu N. Osteoblasts express claudins and tight junction-associated proteins. Histochem Cell Biol 130: 79-90, 2008.
53. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient receptor potential melastatin- and vanilloid-related channels in pulmonary arterial and aortic smooth muscle. Am J Physiol Lung Cell Mol Physiol 290: L1267-L1276, 2006.